SCHEMBL5746992

SCHEMBL5746992

COc1ccc(C#Cc2cc(OC)c(OC(C)C)cc2O)cc1[O]

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE4B Q07343 4/20 0.37
PDE4A P27815 2/20 0.37
PDE4C Q08493 2/20 0.37
PDE4D Q08499 2/20 0.37
ACACB O00763 5/20 0.37
ACHE P22303 1/20 0.35
HTT P42858 1/20 0.35
ALDH1A1 P00352 2/20 0.33
MAPT P10636 2/20 0.33
MAPK1 P28482 1/20 0.33
GAA P10253 1/20 0.33
HPGD P15428 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
TUBB4A P04350 1/20 0.32
TUBB P07437 1/20 0.32
TUBA3C P0DPH7 1/20 0.32
TUBA1B P68363 1/20 0.32
TUBA4A P68366 1/20 0.32
TUBB4B P68371 1/20 0.32
TUBB3 Q13509 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3952203 0.89 ACACB (0.40) PDE4BPDE4APDE4CPDE4DACACB
SCHEMBL3941664 0.89 ACACB (0.42) PDE4BPDE4APDE4CPDE4DACACB
SCHEMBL5747442 0.82 ALDH1A1 (0.39) PDE4BPDE4APDE4CPDE4DACACB
SCHEMBL3946740 0.73 ALDH1A1 (0.41) PDE4BPDE4APDE4CPDE4DACACB
SCHEMBL3941671 0.73 ALDH1A1 (0.41) PDE4BPDE4APDE4CPDE4DACACB
SCHEMBL3943880 0.71 ACACB (0.41) PDE4BPDE4APDE4CPDE4DACACB
SCHEMBL5746990 0.71 ALDH1A1 (0.37) PDE4BACACBACHEALDH1A1MAPT
SCHEMBL3941652 0.71 ACACB (0.44) PDE4BPDE4APDE4CPDE4DACACB
SCHEMBL3236478 0.69 ACACB (0.42) PDE4BPDE4APDE4CPDE4DACACB
SCHEMBL3662959 0.67 ALDH1A1 (0.43) PDE4BACACBACHEHTTALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1613635-A2 SOLID PHASE SYNTHESIS OF ANTITUMORAL COMPOUNDS PHARMA MAR, S.A. (ES) 2006-01-11 EP disclosed
WO-2004073598-A2 SOLID PHASE SYNTHESIS OF ANTITUMORAL COMPOUNDS PHARMA MAR, S.A.U. (ES) 2004-09-02 WO disclosed